Efficacy and safety of add-on sarcosine in patients with major depressive disorder: A randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of add-on sarcosine in patients with major depressive disorder: A randomized controlled trial

Published:2024-10 Issue: Volume:178 Page:298-304
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Padhan Milan,Mohapatra Debadatta,Mishra Biswa Ranjan,Maiti Rituparna^ORCID,Jena Monalisa

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Reference41 articles.

1. AMPA receptor-mTOR activation is required for the antidepressant-like effects of sarcosine during the forced swim test in rats: insertion of AMPA receptor may play a role;Chen;Front. Behav. Neurosci.,2015

2. Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress;Chen;Behav. Brain Res.,2017

3. Ketamine, benzoate, and sarcosine for treating depression;Cheng;Neuropharmacology,2023

4. Delayed antidepressant efficacy and the desensitization hypothesis;Commons;ACS Chem. Neurosci.,2019

5. Cyloserine as an antidepressant agent;Crane;Am. J. Psychiatr.,1959

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP